US Patent Issued to SQ Innovation on June 3 for "Pharmaceutical compositions of furosemide and uses thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,363, issued on June 3, was assigned to SQ Innovation AG (Zug, Switzerland).

"Pharmaceutical compositions of furosemide and uses thereof" was invented by Pieter Muntendam (Boxford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition and a method of administering the pharmaceutical composition to a patient suffering from edema, heart failure, kidney or liver disease or having symptoms thereof are disclosed. The pharmaceutical composition includes furosemide, or a pharmaceutically acceptable salt, hydrate or ester thereof and a cyclodextrin."

The patent was filed on Feb. 10, 2022, under Application No. 17/668,519.

*For fu...